These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 17682090)
1. Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study. Atteritano M; Marini H; Minutoli L; Polito F; Bitto A; Altavilla D; Mazzaferro S; D'Anna R; Cannata ML; Gaudio A; Frisina A; Frisina N; Corrado F; Cancellieri F; Lubrano C; Bonaiuto M; Adamo EB; Squadrito F J Clin Endocrinol Metab; 2007 Aug; 92(8):3068-75. PubMed ID: 17682090 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study. Marini H; Bitto A; Altavilla D; Burnett BP; Polito F; Di Stefano V; Minutoli L; Atteritano M; Levy RM; Frisina N; Mazzaferro S; Frisina A; D'Anna R; Cancellieri F; Cannata ML; Corrado F; Lubrano C; Marini R; Adamo EB; Squadrito F Nutr Metab Cardiovasc Dis; 2010 Jun; 20(5):332-40. PubMed ID: 19631515 [TBL] [Abstract][Full Text] [Related]
3. Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial. Marini H; Minutoli L; Polito F; Bitto A; Altavilla D; Atteritano M; Gaudio A; Mazzaferro S; Frisina A; Frisina N; Lubrano C; Bonaiuto M; D'Anna R; Cannata ML; Corrado F; Adamo EB; Wilson S; Squadrito F Ann Intern Med; 2007 Jun; 146(12):839-47. PubMed ID: 17577003 [TBL] [Abstract][Full Text] [Related]
4. Effects of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women. Crisafulli A; Altavilla D; Marini H; Bitto A; Cucinotta D; Frisina N; Corrado F; D'Anna R; Squadrito G; Adamo EB; Marini R; Romeo A; Cancellieri F; Buemi M; Squadrito F Menopause; 2005 Mar; 12(2):186-92. PubMed ID: 15772566 [TBL] [Abstract][Full Text] [Related]
5. Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study. Marini H; Bitto A; Altavilla D; Burnett BP; Polito F; Di Stefano V; Minutoli L; Atteritano M; Levy RM; D'Anna R; Frisina N; Mazzaferro S; Cancellieri F; Cannata ML; Corrado F; Frisina A; Adamo V; Lubrano C; Sansotta C; Marini R; Adamo EB; Squadrito F J Clin Endocrinol Metab; 2008 Dec; 93(12):4787-96. PubMed ID: 18796517 [TBL] [Abstract][Full Text] [Related]
6. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. Morabito N; Crisafulli A; Vergara C; Gaudio A; Lasco A; Frisina N; D'Anna R; Corrado F; Pizzoleo MA; Cincotta M; Altavilla D; Ientile R; Squadrito F J Bone Miner Res; 2002 Oct; 17(10):1904-12. PubMed ID: 12369794 [TBL] [Abstract][Full Text] [Related]
7. OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. Marini H; Minutoli L; Polito F; Bitto A; Altavilla D; Atteritano M; Gaudio A; Mazzaferro S; Frisina A; Frisina N; Lubrano C; Bonaiuto M; D'Anna R; Cannata ML; Corrado F; Cancellieri F; Faraci M; Marini R; Adamo EB; Wilson S; Squadrito F J Bone Miner Res; 2008 May; 23(5):715-20. PubMed ID: 18433304 [TBL] [Abstract][Full Text] [Related]
8. Genistein in the metabolic syndrome: results of a randomized clinical trial. Squadrito F; Marini H; Bitto A; Altavilla D; Polito F; Adamo EB; D'Anna R; Arcoraci V; Burnett BP; Minutoli L; Di Benedetto A; Di Vieste G; Cucinotta D; de Gregorio C; Russo S; Corrado F; Saitta A; Irace C; Corrao S; Licata G J Clin Endocrinol Metab; 2013 Aug; 98(8):3366-74. PubMed ID: 23824420 [TBL] [Abstract][Full Text] [Related]
9. The differential effect of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women: relationship with the metabolic status. Villa P; Costantini B; Suriano R; Perri C; Macrì F; Ricciardi L; Panunzi S; Lanzone A J Clin Endocrinol Metab; 2009 Feb; 94(2):552-8. PubMed ID: 19017760 [TBL] [Abstract][Full Text] [Related]
10. Genistein aglycone does not affect thyroid function: results from a three-year, randomized, double-blind, placebo-controlled trial. Bitto A; Polito F; Atteritano M; Altavilla D; Mazzaferro S; Marini H; Adamo EB; D'Anna R; Granese R; Corrado F; Russo S; Minutoli L; Squadrito F J Clin Endocrinol Metab; 2010 Jun; 95(6):3067-72. PubMed ID: 20357174 [TBL] [Abstract][Full Text] [Related]
11. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658 [TBL] [Abstract][Full Text] [Related]
12. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease. Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047 [TBL] [Abstract][Full Text] [Related]
13. Genistein effects on quality of life and depression symptoms in osteopenic postmenopausal women: a 2-year randomized, double-blind, controlled study. Atteritano M; Mazzaferro S; Bitto A; Cannata ML; D'Anna R; Squadrito F; Macrì I; Frisina A; Frisina N; Bagnato G Osteoporos Int; 2014 Mar; 25(3):1123-9. PubMed ID: 24114397 [TBL] [Abstract][Full Text] [Related]
14. The hypoglycemic effects of soy isoflavones on postmenopausal women. Cheng SY; Shaw NS; Tsai KS; Chen CY J Womens Health (Larchmt); 2004 Dec; 13(10):1080-6. PubMed ID: 15650341 [TBL] [Abstract][Full Text] [Related]
15. Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and placebo-controlled study. Crisafulli A; Marini H; Bitto A; Altavilla D; Squadrito G; Romeo A; Adamo EB; Marini R; D'Anna R; Corrado F; Bartolone S; Frisina N; Squadrito F Menopause; 2004; 11(4):400-4. PubMed ID: 15243277 [TBL] [Abstract][Full Text] [Related]
16. Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial. Zhang G; Qin L; Shi Y J Bone Miner Res; 2007 Jul; 22(7):1072-9. PubMed ID: 17419678 [TBL] [Abstract][Full Text] [Related]
17. Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial. Ho SC; Chen YM; Ho SS; Woo JL Menopause; 2007; 14(5):905-12. PubMed ID: 17413839 [TBL] [Abstract][Full Text] [Related]
18. Effects of soy isoflavones on endothelial function in healthy postmenopausal women. Colacurci N; Chiàntera A; Fornaro F; de Novellis V; Manzella D; Arciello A; Chiàntera V; Improta L; Paolisso G Menopause; 2005; 12(3):299-307. PubMed ID: 15879919 [TBL] [Abstract][Full Text] [Related]
19. Effects of l-carnitine supplement on serum amyloid A and vascular inflammation markers in hemodialysis patients: a randomized controlled trial. Tabibi H; Hakeshzadeh F; Hedayati M; Malakoutian T J Ren Nutr; 2011 Nov; 21(6):485-91. PubMed ID: 21439850 [TBL] [Abstract][Full Text] [Related]
20. Isoflavones and clinical cardiovascular risk factors in obese postmenopausal women: a randomized double-blind placebo-controlled trial. Aubertin-Leheudre M; Lord C; Khalil A; Dionne IJ J Womens Health (Larchmt); 2008 Oct; 17(8):1363-9. PubMed ID: 18788990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]